Literature DB >> 2460391

Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.

S Kinoyama1, G Yamada, H Okushin, H Mimura, T Kobayashi, T Tsuji.   

Abstract

Alpha-fetoprotein (AFP) synthesis in non-malignant liver tissue of 34 patients with chronic hepatitis or liver cirrhosis, some of whom also had hepatocellular carcinoma (HCC), was studied by light and ultrastructural immunohistochemistry using peroxidase-labeled anti-human AFP. Simultaneously, the serum level of AFP was measured in these patients by radioimmunoassay. AFP-positive cells were identified in non-malignant liver tissue of 7 patients with elevation of serum AFP. AFP was demonstrated in several hepatocytes which were clustered in hepatic lobules, and also in some bile ductular cells which were distributed in the periphery of portal tracts. In an immunoelectron microscopic study of AFP-positive hepatocytes, dense reaction products of anti-AFP were localized in the membranes and cisternae of rough endoplasmic reticulum (r-ER), perinuclear space (PNS) and Golgi apparatus. The prominent feature of AFP-positive hepatocytes was abundant r-ER encompassing many mitochondria. As to AFP-positive bile ductular cells, they had scanty cytoplasm and few intracytoplasmic organelles and were surrounded by basement membrane. AFP was focally localized in the r-ER of such bile ductular cells. These observations suggest that AFP can be produced by malignant and non-malignant liver cells and that in non-malignant liver tissues, AFP can be produced by two distinct cell types; bile ductular cells and hepatocytes themselves.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460391     DOI: 10.1007/bf02779210

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  22 in total

1.  Hepatitis B core and surface antigens in liver tissue. Light and electron microscopic localization by the peroxidase-labeled antibody method.

Authors:  G Yamada; P K Nakane
Journal:  Lab Invest       Date:  1977-06       Impact factor: 5.662

2.  Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus.

Authors:  D Gitlin; A Perricelli; G M Gitlin
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

3.  Embryonal serum alpha-globulin in cancer patients: diagnostic value.

Authors:  G I Abelev; I V Assecritova; N A Kraevsky; S D Perova; N I Perevodchikova
Journal:  Int J Cancer       Date:  1967-09-15       Impact factor: 7.396

4.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

5.  AFP-producing cells in hepatitis and in liver cirrhosis.

Authors:  S Sakamoto; A Yachi; T Anzai; T Wada
Journal:  Ann N Y Acad Sci       Date:  1975-08-22       Impact factor: 5.691

6.  Hepatocellular ultrastructure during liver regeneration after subtotal hepatectomy.

Authors:  R J Stenger; D B Confer
Journal:  Exp Mol Pathol       Date:  1966-10       Impact factor: 3.362

7.  Correlation of histology and alpha 1-fetoprotein resurgence in rat liver regeneration after experimental injury by galactosamine.

Authors:  W D Kuhlmann; K Wurster
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

8.  Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.

Authors:  E Alpert; E R Feller
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

9.  Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.

Authors:  N Eleftheriou; J Heathcote; H C Thomas; S Sherlock
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

10.  Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay.

Authors:  D H Bellet; J R Wands; K J Isselbacher; C Bohuon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.